Sarepta Therapeutics, Inc. (SRPT) stock prices updated...
 

Sarepta Therapeutics, Inc. stock price

Sarepta Therapeutics, Inc. latest news:


  • 01/08/2018 11:49:27

    BRIEF-Sarepta Therapeutics Provides FY 2018 Rev Forecast For Exondys 51

    * SAREPTA THERAPEUTICS PRE-ANNOUNCES FOURTH QUARTER 2017 REVENUE AND PROVIDES FULL-YEAR 2018 REVENUE GUIDANCE FOR EXONDYS 51® (ETEPLIRSEN), REPRESENTING APPROXIMATELY 100 PERCENT YEAR-OVER-YEAR GROWTH

  • 11/10/2017 01:27:07

    BRIEF-Sarepta Therapeutics says exercise of option to purchase additional convertible senior notes due 2024

    * SAREPTA THERAPEUTICS ANNOUNCES EXERCISE OF INITIAL PURCHASERS’ OPTION TO PURCHASE ADDITIONAL CONVERTIBLE SENIOR NOTES DUE 2024 Source text for Eikon: Further company coverage:

  • 11/07/2017 14:47:01

    BRIEF-Sarepta Therapeutics announces proposed offering of $375 mln of convertible senior notes

    Sarepta Therapeutics Inc(SRPT). * Sarepta Therapeutics(SRPT) announces proposed offering of $375 million of convertible senior notes due 2024.

  • More trends:

    SB Financial Group, Inc.SBFG | SB Financial Group, Inc.SBFGP | SBA Communications CorporationSBAC | ScanSource, Inc.SCSC | Schmitt Industries, Inc.SMIT | Schnitzer Steel Industries, Inc.SCHN | Scholastic CorporationSCHL | SciClone Pharmaceuticals, Inc.SCLN | Scientific Games CorpSGMS | SciQuest, Inc.SQI |